Welcome
-
Home
-
Register
-
Login
-
Help/FAQ
-
0 items
Search
Enter keywords, a title or
a report id number below.
In All Categories
---------------------
Telecom & Computing
Business & Finance
Mfg & Construction
Pharma & Healthcare
Consumer & Retail
Gov & Public Sector
Energy & Transport
Country Reports
Company Reports
---------------------
Transcripts
Advanced
Select a currency for use throughout the site
Australia Dollars
Canada Dollars
Euro
Japan Yen
Sweden Kroner
Switzerland Francs
UK Pounds
US Dollars
Viewing report
Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
|
More
Hard Copy
Enterprisewide
Thought Leader Insight & Analysis: Alzheimer's Disease
Medpredict, Jan 2008
Description
Table of Contents
Products Mentioned
Enquire before Buying
Send to a Friend
Send to a Friend
To email a friend details of
Thought Leader Insight & Analysis: Alzheimer's Disease
complete the form below and click on "Send".
*
Required Information
Your Friend's Details
Friend's Full Name
*
Friend's Email Address
*
A message for your Friend
Your Contact Details
Your Name
*
Email Address
*
Customers who bought this item also bought
Wyeth
Alzheimer Disease - New Drugs, Markets and Companies
Central Nervous System Alzheimer Disease
Central Nervous System - Alzheimer Disease Drug Pipeline Report
Emerging Drug Targets in Alzheimer's Disease
Bapineuzumab Phase 2 Clinical Trial Results Call - Wyeth,Elan Corp. Plc, - Earnings Transcript
Bapineuzumab Phase 2 Clinical Trial Results Call - Wyeth,Elan Corp. Plc, - Earnings Transcript
Small Molecule Kinase Inhibitors - Global Strategic Business Report
CNS Drug Discoveries: Alzheimer's Disease Chapter
Acquisition of Wyeth by Pfizer, Inc Call - - Earnings Transcript
Acquisition of Wyeth by Pfizer, Inc Call - - Earnings Transcript
Wyeth: Company Analysis
Top of page
All rights reserved. © Copyright 2009 Research and Markets
0
Terms and conditions
Privacy Policy
Publishers
Employment Opportunities
Site Map
Link to us
Webmaster
